Celldex Therapeutics
CLDX
$36.30
Share price
0.11%
Change (1 day)
12.28%
Change (1 year)
Categories
EPS for Celldex Therapeutics (CLDX)
EPS in 2023 (TTM): -$2.40
According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.40. In 2022 the company made an earnings per share (EPS) of -$2.39 a decrease over its 2021 EPS that were of -$1.64.
EPS history for Celldex Therapeutics from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.40 | 0.42% |
| 2022 | -$2.39 | 45.73% |
| 2021 | -$1.64 | -23.36% |
| 2020 | -$2.14 | -41.05% |
| 2019 | -$3.63 | -76.95% |
| 2018 | -$15.75 | 45.03% |
| 2017 | -$10.86 | -42.54% |
| 2016 | -$18.90 | -3.82% |
| 2015 | -$19.65 | -0.76% |
| 2014 | -$19.80 | 29.41% |
| 2013 | -$15.30 | 0% |
| 2012 | -$15.30 | -9.73% |
| 2011 | -$16.95 | 1312.5% |
| 2010 | -$1.20 | -95.79% |
| 2009 | -$28.48 | -49.64% |
| 2008 | -$56.55 | -82.64% |
| 2007 | -$325.80 | -44.98% |
| 2006 | -$592.20 | 1270.83% |
| 2005 | -$43.20 | 33.33% |
| 2004 | -$32.40 | -10% |
| 2003 | -$36.00 | -16.67% |
| 2002 | -$43.20 | -38.46% |
| 2001 | -$70.20 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -177.50% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | -689.58% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -245.86% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | -$0.57 | -76.25% | 🇺🇸 USA |
 Seagen
SGEN | -$4.01 | 67.08% | 🇺🇸 USA |
 Agenus
AGEN | -$0.85 | -64.58% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$12.08 | 403.33% | 🇺🇸 USA |